Literature DB >> 18443096

New adhesin of enteroaggregative Escherichia coli related to the Afa/Dr/AAF family.

Nadia Boisen1, Carsten Struve, Flemming Scheutz, Karen A Krogfelt, James P Nataro.   

Abstract

Enteroaggregative Escherichia coli (EAEC) is an important cause of diarrhea worldwide. We analyzed 17 Danish EAEC strains, isolated in the course of a case control study, for phenotypic and genotypic properties. The strains belonged to at least 14 different serotypes. Using PCR to investigate the prevalence of various putative virulence genes, we found that all but two strains were typical EAEC, as they harbored all or part of the previously described AggR regulon. The majority of the strains harbored genes encoding aggregative adherence fimbriae (AAF). The most common was AAF/I, found in nine strains; eight strains carried no known AAF-related genes. We utilized TnphoA mutagenesis to localize the aggregative adherence (AA) adhesin from one typical EAEC strain, C1010-00, which lacked a known AAF. We identified a TnphoA insertion in a hypothetical Dr-related pilin deposited in GenBank as HdaA. Four additional Danish strains harbored HdaA, and all but one displayed AA to HEp-2 cells. By using PCR primers derived from the pilins and ushers from the three AAF and Hda, we found that 16 of 17 strains exhibited evidence of one of these factors; importantly, the one negative strain also lacked the aggR gene. Cloning of the complete Hda gene cluster and expression in E. coli DH5alpha resulted in AA and complementation of the C1010-00 nonadherent mutant. Four related adhesins have now been found to confer AA in typical EAEC strains; our data suggest that, together, these variants may account for AA in the large majority of strains.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443096      PMCID: PMC2446688          DOI: 10.1128/IAI.01646-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  68 in total

Review 1.  Virulence functions of autotransporter proteins.

Authors:  I R Henderson; J P Nataro
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  afa-8 Gene cluster is carried by a pathogenicity island inserted into the tRNA(Phe) of human and bovine pathogenic Escherichia coli isolates.

Authors:  L Lalioui; C Le Bouguénec
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

3.  Distribution and expression of the astA gene (EAST1 toxin) in Escherichia coli and Salmonella.

Authors:  C Paiva de Sousa; J D Dubreuil
Journal:  Int J Med Microbiol       Date:  2001-04       Impact factor: 3.473

4.  Diarrheagenic Escherichia coli infection in Baltimore, Maryland, and New Haven, Connecticut.

Authors:  James P Nataro; Volker Mai; Judith Johnson; William C Blackwelder; Robert Heimer; Shirley Tirrell; Stephen C Edberg; Christopher R Braden; J Glenn Morris; Jon Mark Hirshon
Journal:  Clin Infect Dis       Date:  2006-07-11       Impact factor: 9.079

5.  Roles for Fis and YafK in biofilm formation by enteroaggregative Escherichia coli.

Authors:  J Sheikh; S Hicks; M Dall'Agnol; A D Phillips; J P Nataro
Journal:  Mol Microbiol       Date:  2001-09       Impact factor: 3.501

6.  Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world.

Authors:  J A Adachi; Z D Jiang; J J Mathewson; M P Verenkar; S Thompson; F Martinez-Sandoval; R Steffen; C D Ericsson; H L DuPont
Journal:  Clin Infect Dis       Date:  2001-05-21       Impact factor: 9.079

7.  A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea.

Authors:  David N Taylor; A Louis Bourgeois; Charles D Ericsson; Robert Steffen; Zhi-Dong Jiang; Jane Halpern; Robert Haake; Herbert L Dupont
Journal:  Am J Trop Med Hyg       Date:  2006-06       Impact factor: 2.345

8.  Proteomic and microarray characterization of the AggR regulon identifies a pheU pathogenicity island in enteroaggregative Escherichia coli.

Authors:  Edward G Dudley; Nicholas R Thomson; Julian Parkhill; Nicholas P Morin; James P Nataro
Journal:  Mol Microbiol       Date:  2006-09       Impact factor: 3.501

9.  Enteroaggregative Escherichia coli in Venda, South Africa: distribution of virulence-related genes by multiplex polymerase chain reaction in stool samples of human immunodeficiency virus (HIV)-positive and HIV-negative individuals and primary school children.

Authors:  Amidou Samie; Chikwelu Larry Obi; Rebecca Dillingham; Relana C Pinkerton; Richard L Guerrant
Journal:  Am J Trop Med Hyg       Date:  2007-07       Impact factor: 2.345

10.  The cysteine bond in the Escherichia coli FimH adhesin is critical for adhesion under flow conditions.

Authors:  Lina M Nilsson; Olga Yakovenko; Veronika Tchesnokova; Wendy E Thomas; Mark A Schembri; Viola Vogel; Per Klemm; Evgeni V Sokurenko
Journal:  Mol Microbiol       Date:  2007-09       Impact factor: 3.501

View more
  74 in total

1.  Analyzing of expression of novel polypeptide complexes consisting of Shiga toxin B subunit and Adherence Fimbriae of Escherichia coli based on in silico modeling.

Authors:  Zeinab Noroozian; Mana Oloomi; Saeid Bouzari
Journal:  J Mol Model       Date:  2012-04-24       Impact factor: 1.810

2.  The fimbriae of enteroaggregative Escherichia coli induce epithelial inflammation in vitro and in a human intestinal xenograft model.

Authors:  Erik J Boll; Carsten Struve; Anja Sander; Zachary Demma; James P Nataro; Beth A McCormick; Karen A Krogfelt
Journal:  J Infect Dis       Date:  2012-06-21       Impact factor: 5.226

3.  QseC Signaling in the Outbreak O104:H4 Escherichia coli Strain Combines Multiple Factors during Infection.

Authors:  Tamara Renata Machado Ribeiro; Bruna Cardinali Lustri; Waldir P Elias; Cristiano Gallina Moreira
Journal:  J Bacteriol       Date:  2019-08-08       Impact factor: 3.490

4.  Crystallization and sulfur SAD phasing of AggA, the major subunit of aggregative adherence fimbriae type I from the Escherichia coli strain that caused an outbreak of haemolytic-uraemic syndrome in Germany.

Authors:  Natalia Pakharukova; Minna Tuittila; Anton Zavialov
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-11-29

5.  Crystallization and initial crystallographic analysis of AafA: the major adhesive subunit of the enteroaggregative Escherichia coli AAF/II pilus.

Authors:  Yi Yang; James A Garnett; Stephen Matthews
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-03-25

Review 6.  Epidemiology and clinical manifestations of enteroaggregative Escherichia coli.

Authors:  Betina Hebbelstrup Jensen; Katharina E P Olsen; Carsten Struve; Karen Angeliki Krogfelt; Andreas Munk Petersen
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

Review 7.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

8.  Nitazoxanide inhibits biofilm production and hemagglutination by enteroaggregative Escherichia coli strains by blocking assembly of AafA fimbriae.

Authors:  Eliah R Shamir; Michelle Warthan; Sareena P Brown; James P Nataro; Richard L Guerrant; Paul S Hoffman
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

9.  Prevalence of enteroaggregative Escherichia coli and its virulence-related genes in a case-control study among children from north-eastern Brazil.

Authors:  Ila Fernanda Nunes Lima; Nadia Boisen; Josiane da Quetz Silva; Alexandre Havt; Eunice Bobo de Carvalho; Alberto Melo Soares; Noélia Leal Lima; Rosa Maria Salani Mota; James P Nataro; Richard Littleton Guerrant; Aldo Ângelo Moreira Lima
Journal:  J Med Microbiol       Date:  2013-02-21       Impact factor: 2.472

Review 10.  Molecular mechanisms of Escherichia coli pathogenicity.

Authors:  Matthew A Croxen; B Brett Finlay
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.